Demant A/S : H1 2022 results due 16 August – Solid performance continues
>Outperformance of hearing aid market - Q2 revenues of DKK 4,979m (+6.6% y-o-y) should be pushed by organic growth of 4.5%, external growth of 1.5%, a negative contribution of 315bp related to the divestment of hearing implants and forex tailwind of 360bp. For the wholesale hearing aid business, we expect the strong performance over the last quarters to continue with organic growth of 7.5%, which is an outperformance of the global hearing aid market (around 4% growth...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.